{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T12:14:05Z","timestamp":1779106445362,"version":"3.51.4"},"reference-count":56,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2014,7,28]],"date-time":"2014-07-28T00:00:00Z","timestamp":1406505600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0102764","type":"journal-article","created":{"date-parts":[[2014,7,28]],"date-time":"2014-07-28T17:57:52Z","timestamp":1406570272000},"page":"e102764","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Differential Peripheral Blood Gene Expression Profile Based on Her2 Expression on Primary Tumors of Breast Cancer Patients"],"prefix":"10.1371","volume":"9","author":[{"given":"Oana","family":"Tudoran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oana","family":"Virtic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loredana","family":"Balacescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Pop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flaviu","family":"Dragla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandru","family":"Eniu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bogdan","family":"Fetica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ovidiu","family":"Balacescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioana","family":"Berindan-Neagoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,7,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","article-title":"Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications","volume":"98","author":"T Sorlie","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"CM Perou","year":"2000","journal-title":"Nature"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.1073\/pnas.0932692100","article-title":"Repeated observation of breast tumor subtypes in independent gene expression data sets","volume":"100","author":"T Sorlie","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1001\/jama.295.21.2492","article-title":"Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study","volume":"295","author":"LA Carey","year":"2006","journal-title":"JAMA"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1471-2164-7-96","article-title":"The molecular portraits of breast tumors are conserved across microarray platforms","volume":"7","author":"Z Hu","year":"2006","journal-title":"BMC Genomics"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1471-2164-7-127","article-title":"Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms","volume":"7","author":"T Sorlie","year":"2006","journal-title":"BMC Genomics"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"6100","DOI":"10.1158\/1078-0432.CCR-10-1533","article-title":"Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study","volume":"16","author":"KM O'Brien","year":"2010","journal-title":"Clin Cancer Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"e1000279","DOI":"10.1371\/journal.pmed.1000279","article-title":"Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies","volume":"7","author":"FM Blows","year":"2010","journal-title":"PLoS Med"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Dent S, Oyan B, Honig A, Mano M, Howell S (2013) HER2-targeted therapy in breast cancer: A systematic review of neoadjuvant trials. Cancer Treat Rev.","DOI":"10.1016\/j.ctrv.2013.01.002"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.breast.2013.08.007","article-title":"Another review on triple negative breast cancer. Are we on the right way towards the exit from the labyrinth?","volume":"22","author":"R Chiorean","year":"2013","journal-title":"Breast"},{"key":"ref11","first-page":"6069","article-title":"Disease-associated expression profiles in peripheral blood mononuclear cells from patients with advanced renal cell carcinoma","volume":"63","author":"NC Twine","year":"2003","journal-title":"Cancer Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1158\/1078-0432.CCR-07-1801","article-title":"Novel blood-based, five-gene biomarker set for the detection of colorectal cancer","volume":"14","author":"M Han","year":"2008","journal-title":"Clin Cancer Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1158\/1078-0432.1181.11.3","article-title":"Transcriptional profiles in peripheral blood mononuclear cells prognostic of clinical outcomes in patients with advanced renal cell carcinoma","volume":"11","author":"ME Burczynski","year":"2005","journal-title":"Clin Cancer Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1186\/bcr2472","article-title":"Gene expression profiling of peripheral blood cells for early detection of breast cancer","volume":"12","author":"J Aaroe","year":"2010","journal-title":"Breast Cancer Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"R634","DOI":"10.1186\/bcr1203","article-title":"Early detection of breast cancer based on gene-expression patterns in peripheral blood cells","volume":"7","author":"P Sharma","year":"2005","journal-title":"Breast Cancer Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3816\/CBC.2008.n.028","article-title":"Basal breast cancer molecular subtype predicts for lower incidence of axillary lymph node metastases in primary breast cancer","volume":"8","author":"SJ Crabb","year":"2008","journal-title":"Clin Breast Cancer"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e20297","DOI":"10.1371\/journal.pone.0020297","article-title":"The molecular subtype classification is a determinant of sentinel node positivity in early breast carcinoma","volume":"6","author":"F Reyal","year":"2011","journal-title":"PLoS One"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S1470-2045(12)70209-7","article-title":"Circulating tumour cells in non-metastatic breast cancer: a prospective study","volume":"13","author":"A Lucci","year":"2012","journal-title":"Lancet Oncol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"R39","DOI":"10.1186\/bcr2326","article-title":"Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer","volume":"11","author":"C Alix-Panabieres","year":"2009","journal-title":"Breast Cancer Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/sj.bjc.6605183","article-title":"Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer","volume":"101","author":"A Daskalaki","year":"2009","journal-title":"Br J Cancer"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11670-012-0143-6","article-title":"HER2-specific T lymphocytes kill both trastuzumab-resistant and trastuzumab-sensitive breast cell lines in vitro","volume":"24","author":"XL Lin","year":"2012","journal-title":"Chin J Cancer Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"11438","DOI":"10.1158\/0008-5472.CAN-07-1882","article-title":"Amino-biphosphonate-mediated MMP-9 inhibition breaks the tumor-bone marrow axis responsible for myeloid-derived suppressor cell expansion and macrophage infiltration in tumor stroma","volume":"67","author":"C Melani","year":"2007","journal-title":"Cancer Res"},{"key":"ref23","first-page":"203","article-title":"Comparison between real-time quantitative PCR detection of HER2 mRNA copy number in peripheral blood and ELISA of serum HER2 protein for determining HER2 status in breast cancer patients","volume":"31","author":"M Savino","year":"2009","journal-title":"Cell Oncol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cca.2007.05.023","article-title":"Development of real-time quantitative reverse transcription-PCR for Her2 detection in peripheral blood from patients with breast cancer","volume":"384","author":"M Savino","year":"2007","journal-title":"Clin Chim Acta"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s11670-012-0213-9","article-title":"Effect of Trastuzumab on Notch-1 Signaling Pathway in Breast Cancer SK-BR3 Cells","volume":"24","author":"M Han","year":"2012","journal-title":"Chin J Cancer Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/onc.2011.279","article-title":"Modeling ductal carcinoma in situ: a HER2-Notch3 collaboration enables luminal filling","volume":"31","author":"CR Pradeep","year":"2012","journal-title":"Oncogene"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1158\/0008-5472.CAN-04-2353","article-title":"ErbB2 promotes Src synthesis and stability: novel mechanisms of Src activation that confer breast cancer metastasis","volume":"65","author":"M Tan","year":"2005","journal-title":"Cancer Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11010-011-1125-6","article-title":"NOTCH1 regulates migration and invasion of skin cancer cells by E-cadherin repression","volume":"362","author":"Z Wang","year":"2012","journal-title":"Mol Cell Biochem"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"8648","DOI":"10.1128\/MCB.00866-07","article-title":"An EGR2\/CITED1 transcription factor complex and the 14-3-3sigma tumor suppressor are involved in regulating ErbB2 expression in a transgenic-mouse model of human breast cancer","volume":"27","author":"RL Dillon","year":"2007","journal-title":"Mol Cell Biol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.immuni.2011.08.007","article-title":"Genome-wide analyses of transcription factor GATA3-mediated gene regulation in distinct T cell types","volume":"35","author":"G Wei","year":"2011","journal-title":"Immunity"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1038\/sj.onc.1208356","article-title":"Cyclin A1, the alternative A-type cyclin, contributes to G1\/S cell cycle progression in somatic cells","volume":"24","author":"P Ji","year":"2005","journal-title":"Oncogene"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1038\/sj.onc.1201972","article-title":"Src kinases and not JAKs activate STATs during IL-3 induced myeloid cell proliferation","volume":"16","author":"P Chaturvedi","year":"1998","journal-title":"Oncogene"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.4049\/jimmunol.171.6.2896","article-title":"Notch signaling augments T cell responsiveness by enhancing CD25 expression","volume":"171","author":"SH Adler","year":"2003","journal-title":"J Immunol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.coi.2004.09.006","article-title":"Regulatory T cells and transcription factors: gatekeepers in allergic inflammation","volume":"16","author":"SM Wahl","year":"2004","journal-title":"Curr Opin Immunol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1073\/pnas.1017729108","article-title":"14-3-3sigma regulates B-cell homeostasis through stabilization of FOXO1","volume":"108","author":"YW Su","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"7811","DOI":"10.4049\/jimmunol.177.11.7811","article-title":"Cyclooxygenase-2 inhibition attenuates antibody responses against human papillomavirus-like particles","volume":"177","author":"EP Ryan","year":"2006","journal-title":"J Immunol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1158\/1078-0432.CCR-11-2701","article-title":"Molecular pathways: involvement of immune pathways in the therapeutic response and outcome in breast cancer","volume":"19","author":"F Andre","year":"2013","journal-title":"Clin Cancer Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1200\/JCO.2011.39.5624","article-title":"Gene modules and response to neoadjuvant chemotherapy in breast cancer subtypes: a pooled analysis","volume":"30","author":"M Ignatiadis","year":"2012","journal-title":"J Clin Oncol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"R126","DOI":"10.1186\/bcr3072","article-title":"Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer","volume":"13","author":"NR West","year":"2011","journal-title":"Breast Cancer Res"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00281-011-0261-0","article-title":"Anti-cancer immune response mechanisms in neoadjuvant and targeted therapy","volume":"33","author":"C Denkert","year":"2011","journal-title":"Semin Immunopathol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0304-3835(02)00582-7","article-title":"Cyclin A1 is highly expressed in aggressive testicular germ cell tumors","volume":"190","author":"C Muller-Tidow","year":"2003","journal-title":"Cancer Lett"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/ijc.11573","article-title":"Elevated levels and distinct patterns of expression of A-type cyclins and their associated cyclin-dependent kinases in male germ cell tumors","volume":"108","author":"C Liao","year":"2004","journal-title":"Int J Cancer"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s00018-006-5521-5","article-title":"Cyclin A1 is a p53-induced gene that mediates apoptosis, G2\/M arrest, and mitotic catastrophe in renal, ovarian, and lung carcinoma cells","volume":"63","author":"A Rivera","year":"2006","journal-title":"Cell Mol Life Sci"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"6478","DOI":"10.1073\/pnas.0401139101","article-title":"The Six1 homeoprotein stimulates tumorigenesis by reactivation of cyclin A1","volume":"101","author":"RD Coletta","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1471-2407-6-55","article-title":"Cyclin A1 promoter hypermethylation in human papillomavirus-associated cervical cancer","volume":"6","author":"N Kitkumthorn","year":"2006","journal-title":"BMC Cancer"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1046\/j.1365-2141.2003.04569.x","article-title":"Elevated levels of cyclin A1 and A (A2) mRNA in acute myeloid leukaemia are associated with increased survival","volume":"123","author":"T Nakamaki","year":"2003","journal-title":"Br J Haematol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3816\/CBC.2007.n.054","article-title":"Molecular detection and prognostic value of circulating cytokeratin-19 messenger RNA-positive and HER2 messenger RNA-positive cells in the peripheral blood of women with early-stage breast cancer","volume":"7","author":"M Ignatiadis","year":"2007","journal-title":"Clin Breast Cancer"},{"key":"ref48","first-page":"4569","article-title":"Expression of angiogenic markers in the peripheral blood of patients with advanced breast cancer treated with weekly docetaxel","volume":"32","author":"I Korantzis","year":"2012","journal-title":"Anticancer Res"},{"key":"ref49","first-page":"7641","article-title":"DNA methylation in serum of breast cancer patients: an independent prognostic marker","volume":"63","author":"HM Muller","year":"2003","journal-title":"Cancer Res"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.clinbiochem.2009.04.003","article-title":"Prognostic significance of RASSF1A promoter methylation in operable breast cancer","volume":"42","author":"M Kioulafa","year":"2009","journal-title":"Clin Biochem"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10549-010-1335-8","article-title":"Prognostic significance of methylated RASSF1A and PITX2 genes in blood- and bone marrow plasma of breast cancer patients","volume":"130","author":"G Gobel","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"ref52","first-page":"2975","article-title":"RASSF1A methylation is predictive of poor prognosis in female breast cancer in a background of overall low methylation frequency","volume":"31","author":"A Buhmeida","year":"2011","journal-title":"Anticancer Res"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/1471-2407-12-243","article-title":"Methylation of HIN-1, RASSF1A, RIL and CDH13 in breast cancer is associated with clinical characteristics, but only RASSF1A methylation is associated with outcome","volume":"12","author":"J Xu","year":"2012","journal-title":"BMC Cancer"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"R57","DOI":"10.1186\/bcr1762","article-title":"Correlation between CpG methylation profiles and hormone receptor status in breast cancers","volume":"9","author":"W Feng","year":"2007","journal-title":"Breast Cancer Res"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/ijc.11162","article-title":"Evaluation of hypermethylated tumor suppressor genes as tumor markers in mouth and throat rinsing fluid, nasopharyngeal swab and peripheral blood of nasopharygeal carcinoma patient","volume":"105","author":"HW Chang","year":"2003","journal-title":"Int J Cancer"},{"key":"ref56","first-page":"2489","article-title":"Aberrant promoter hypermethylation and genomic hypomethylation in tumor, adjacent normal tissues and blood from breast cancer patients","volume":"30","author":"YH Cho","year":"2010","journal-title":"Anticancer Res"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0110962","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2014,10,13]],"date-time":"2014-10-13T00:00:00Z","timestamp":1413158400000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0102764","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T14:47:56Z","timestamp":1689432476000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0102764"}},"subtitle":[],"editor":[{"given":"Javier S.","family":"Castresana","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,7,28]]},"references-count":56,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2014,7,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0102764","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,28]]}}}